General InformationAltos Labs is a cellular reprogramming company based in California with 200-500 employees, founded in 2021, focused on reversing aging through epigenetic and cellular rejuvenation technologies.
Funding & FinancialsThe company has raised over $350 million in funding including a Series C round led by major venture investors and strategic partners, with backing from prominent deep-tech and longevity-focused funds.
Leadership & TeamAltos Labs was co-founded by Richard Klausner (former National Cancer Institute director) as CEO, along with leading scientists including Juan Carlos Izpisúa Belmonte and other prominent aging and cell biology researchers.
Recent ActivityThe company has published peer-reviewed research on cellular reprogramming and aging reversal, established research centers globally, and expanded partnerships with academic institutions and pharmaceutical collaborators in the longevity space.